Product released to agreed specification and delivered to client or designated location with full batch documentation.
Sterile contract manufacturing for peptide-based programmes at development and institutional scale. Thanet Labs accepts enquiries for process development, analytical method validation, aseptic fill and finish, and lyophilisation. Services are subject to applicable MHRA manufacturing authorisation. Feasibility and next steps confirmed within two working days of enquiry.
Partnership
Thanet Labs is building a UK sterile peptide manufacturing platform designed to support programmes from early development through to institutional supply. Contract manufacturing services are structured around the needs of research institutions, pharmaceutical developers, and biotech organisations working with peptide APIs, small molecules, and biologic preparations.
Rather than a one-size-fits-all production model, Thanet Labs works with clients to define the appropriate manufacturing pathway for each compound — taking into account formulation requirements, batch size, documentation expectations, and the intended supply route. Development-stage enquiries are welcomed, including programmes where analytical methods, lyophilisation cycles, or fill parameters are still being established.
Scope
Contract manufacturing at Thanet Labs encompasses the full downstream manufacturing process for sterile peptide presentations. This includes formulation review and process development, aseptic fill and finish into sterile glass vials, lyophilisation where required, in-process analytical testing, and the compilation of batch documentation to GMP-aligned standards.
Thanet Labs does not perform peptide synthesis. Clients supply the bulk peptide API, and Thanet Labs provides the manufacturing infrastructure to convert it into a finished, documented sterile presentation. This model is particularly suited to research institutions and pharmaceutical developers who have synthesised or sourced their compound and require a UK-based fill and finish partner.
Capabilities
Compound types
Peptide APIs, small molecules, biologic preparations
Presentations
Sterile liquid vials, lyophilised vials
Vial sizes
2 mL – 10 mL sterile glass
Batch scale
Development runs to institutional supply volumes
Process development
Available for new programmes
Analytical support
Method development and validation available
Documentation
Batch records, certificate of analysis, in-process data
Supply route
Confirmed at project scoping stage
Contract manufacturing services are subject to applicable MHRA manufacturing authorisation. Thanet Labs is currently in the process of obtaining its Manufacturer’s Specials Licence (MSL). Enquiries for development-stage programmes are accepted now; commercial supply timelines will be confirmed based on licensing progress.
